Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 728 across all filing types
Latest filing 2023-07-07 Share Issue/Capital Cha…
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
港股公告：证券变动月报表
Share Issue/Capital Change Classification · 100% confidence The document is a monthly report detailing changes in the company's share capital and issued shares as of June 30, 2023. It includes detailed tables on statutory/registered capital changes, issued share changes, share options, and confirmations related to share issuance. The document is addressed to the Hong Kong Stock Exchange and references compliance with listing rules. The content focuses on share capital changes and issuance details rather than financial performance, management changes, or other report types. The document length is 4627 characters, which is sufficient to contain substantive data rather than just an announcement. This matches the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues or capital changes. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2023-07-07 Chinese
港股公告：授出购股权及受限制股份单位
Regulatory Filings Classification · 95% confidence The document is a formal announcement regarding the grant of share options and restricted share units under the company's 2016 Option and Incentive Plan. It details the number of shares/options granted, exercise prices, vesting schedules, and related terms. The document references compliance with listing rules and is dated July 6, 2023. It does not contain financial statements or results, nor is it a report or presentation. It is a regulatory announcement about equity compensation grants to employees, which fits the category of Regulatory Filings (RNS) as it does not fit other more specific categories like Remuneration Information (DEF 14A) because it is not a detailed compensation report but a grant announcement. The document length is 3501 characters, which is relatively short and typical for such announcements. Therefore, the best classification is Regulatory Filings (RNS).
2023-07-07 Chinese
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 95% confidence The document is a detailed disclosure report about changes in issued share capital and/or share repurchases by the company 百濟神州有限公司, registered in the Cayman Islands. It references specific Hong Kong Stock Exchange Listing Rules (Main Board Rule 13.25A and GEM Rule 17.27A) which require disclosure of share capital changes. The document includes detailed tables of share issuance and repurchase data, dates, share counts, prices, and percentages. It also contains formal confirmations by the company's executive director and CEO regarding the authorization and compliance of the share issuances. The document length is 3765 characters, which is relatively short but contains substantive data on share capital changes, not just an announcement or a link to a report. This matches the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues, stock splits, or other capital changes. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2023-07-03 Chinese
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 95% confidence The document is a detailed disclosure report about changes in issued share capital and/or share repurchases by the company 百濟神州有限公司, registered in the Cayman Islands. It references specific Hong Kong Stock Exchange Listing Rules (Main Board Rule 13.25A and GEM Rule 17.27A) which require disclosure of share capital changes. The document includes detailed tables of share issuance, dates, share counts, prices, and percentage changes. It also contains formal statements confirming board authorization and compliance with listing rules. The document length is 3732 characters, which is relatively short but contains substantive data on share capital changes rather than just an announcement or a link to a report. This fits the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues, stock splits, or other capital changes. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2023-06-29 Chinese
港股公告：翌日披露报表
Share Issue/Capital Change Classification · 100% confidence The document is a disclosure report related to changes in issued share capital and/or share repurchases by the company, as required under the Hong Kong Stock Exchange Listing Rules (Main Board and GEM). It details share issuance under share award plans, dates, share counts, prices, and compliance confirmations by the company's board. The document is titled as a "翌日披露報表" which translates to "Next Day Disclosure Report" and is a regulatory disclosure of share capital changes. It is not a full financial report, earnings release, or management discussion. It is a formal announcement of share capital changes and share issuance details, fitting the category of Share Issue/Capital Change announcements. The document length is under 5,000 characters, but it contains detailed share issuance data, not just a notice of report publication. Therefore, it is classified as a Share Issue/Capital Change (SHA).
2023-06-25 Chinese
港股公告：授出购股权及受限制股份单位
Director's Dealing Classification · 95% confidence The document is a detailed announcement regarding the grant of share options and restricted share units under the 2016 Option and Incentive Plan by BeiGene, Ltd. It includes specifics about the number of shares granted, exercise prices, vesting schedules, recipients including directors and employees, and compliance with listing rules. The document is not a financial report, earnings release, or management discussion, but rather a formal disclosure of share-based compensation awards to directors and senior executives. This type of disclosure aligns with announcements of director dealings or insider share transactions. Given the detailed nature of the share option and restricted share unit grants to directors and executives, and the focus on share awards rather than financial results or governance policies, the most appropriate classification is Director's Dealing (DIRS). The document is substantive and not a brief announcement or a report publication notice, so it is not RPA or RNS. Confidence is high due to the clear focus on share grants to directors and executives.
2023-06-20 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.